Therefore, clinically meaningful cancers have several mechanisms involved in immunosuppression, such as enhancing different cells to participate in immunosuppression and enhancing various molecules to participate in immunosuppression, including CTLA4, PD1, PDL1, LAG3 and other immune checkpoints. The gene discussed is PDCD1; the disease is cancer.